A case report describes reversible dropped head syndrome linked to olanzapine-associated cervical dystonia
Original source
Reversible Dropped Head Syndrome Due to Olanzapine-Associated Cervical Dystonia in a Patient With C9orf72-Associated bvFTD Within the FTD-ALS Spectrum. (opens in a new tab)Compass holds only the headline and link for this source, so the summary below is necessarily brief. Please read the original.
Related topics
A journal article reports reversible dropped head syndrome in a patient with C9orf72-associated behavioural variant frontotemporal dementia (bvFTD). The title attributes the condition to olanzapine-associated cervical dystonia and places the case within the frontotemporal dementia–amyotrophic lateral sclerosis spectrum.
Why this matters
This may be relevant to clinicians assessing dropped head symptoms in people with frontotemporal dementia or related ALS-spectrum disease, particularly when olanzapine is being used. It is a report about one patient and does not establish a treatment recommendation or change care for people with ALS/MND generally.
Limitations and context
This is a single journal case report, and only its title and publication metadata were available. The report’s clinical details, methods and evidence for reversibility cannot be assessed here. The findings need confirmation in additional patients.